Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
986,261
-
Share change
-
+209,689
-
Total reported value
-
$1,903,480
-
Price per share
-
$1.93
-
Number of holders
-
27
-
Value change
-
+$401,694
-
Number of buys
-
15
-
Number of sells
-
9
Institutional Holders of Dare Bioscience, Inc. - COM NEW (DARE) as of Q4 2025
As of 31 Dec 2025,
Dare Bioscience, Inc. - COM NEW (DARE) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
986,261 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA INVESTMENTS, LP, STATE STREET CORP, US BANCORP \DE\, UBS Group AG, RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, and TWO SIGMA ADVISERS, LP.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.